作为心力衰竭的潜在生物标志物,射分数>45%的甲烯:一个前性队列研究
Paula Alexandra Vulciu1, Luminita Pilat1, Norberth-Istvan Varga2
1Department of Biochemistry, "Vasile Goldis" Western University, B-dul Revolutiei Nr. 96, 310025 Arad, Romania.
Romanian journal of internal medicine = Revue roumaine de medecine interne
|September 17, 2025
概括
血清四分红素 (TETRA) 水平随着心力衰竭 (HF) 严重程度的恶化而下降. 较低的TETRA可能表明HF患者的死亡风险增加,其中保留了喷射分数,尽管需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 心脏衰竭研究研究
背景情况:
- 左心室喷射率 (LVEF) >45%的心力衰竭 (HF) 缺乏可靠的风险分层生物标志物.
- 这一组包括心力衰竭与保留喷射率 (HFpEF) 和轻微减少喷射率 (HFmrEF).
- 准确的风险评估对于管理这些HF亚型至关重要.
研究的目的:
- 为了评估血清四素 (TETRA) 作为HF和LVEF>45%的患者的新生物标志物.
- 评估TETRA水平与疾病严重程度之间的关联.
- 确定TETRA是否可以预测该患者群体的全因死亡率.
主要方法:
- 对116名患有HF和LVEF>45%的患者进行前性队列研究.
- 用ELISA测量的血清TETRA水平,按NYHA类分层.
- 评估了心声学参数,NT-proBNP和12个月全因死亡率.
主要成果:
- 随着NYHA类的增加,TETRA水平显著下降 (p < 0.001).
- TETRA显示了与NT-proBNP,E/e'比率和LAVI的反相关性.
- 在无变量分析中,较低的TETRA水平与较高的死亡风险相关 (p = 0.045).
结论:
- 血清TETRA水平与HF的疾病严重程度相反相关,EF>45%.
- 在这些HF亚型中,TETRA可以作为反映疾病进展的潜在生物标志物.
- 需要进一步的研究来证实TETRA在调整其他因素后的预后价值.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
541
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
801
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
801
01:30Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
01:29Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
01:30Heart Failure IV: Classification and Diagnostic Evaluation
323
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323